Biotech Stocks: European drug makers rally in early action

Tuesday, J&J reported better-than-expected first-quarter earnings and lifted its 2011 financial forecast. Breaking from the upward trend was Abbott Laboratories (NYSE:ABT) Early Wednesday, Abbott reported better-than-expected quarterly earnings, but did...